Therapies For Inherited Neuropathies Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2017 | 87,550 | 640 | 86,910 | 1629.6 | — |
| 2018 | 128,850 | 41,634 | 87,216 | 50.2 | — |
| 2019 | 222,300 | 146,566 | 75,734 | 20.5 | 0% |
| 2020 | 379,008 | 195,292 | 183,716 | 26.7 | 0% |
| 2021 | 191,310 | 222,193 | −30,883 | 21.8 | 0% |
| 2022 | 277,056 | 370,258 | −93,202 | 10.0 | 0% |
| 2023 | 232,876 | 119,104 | 113,772 | 42.7 | 0% |
In its most recent public year (2023), this organization brought in $113,772 more than it spent. Its reserves stood at about 42.7 months of spending, down from 1629.6 in 2017. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Therapies For Inherited Neuropathies Inc's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works